Company News in the Life Science Industry

»

Reset 

Oncolytics Biotech® to Present at the Phacilitate Immuno-Oncology Frontiers Conference

Dr. Andres Gutierrez, Oncolytics' Chief Medical Officer, to present on the clinical progress and robust safety findings of using reovirus as an immuno-oncology viral agent to treat cancer

Read more ››
By: PR Newswire Association LLC. - 19 Sep 2017
Related companies:  Western Oncolytics

Disarm Therapeutics Unveils Breakthrough Approach to Treat Patients with Neurological Diseases by Preventing Axonal Degeneration

CAMBRIDGE, Mass., Sept. 19, 2017 /PRNewswire/ -- Disarm Therapeutics, a new biotechnology company developing therapeutics to treat patients with neurological diseases by preventing axonal degeneration, today announced the recent completion of a $30 million Series A financing. The round was led... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2017

Anti-Chemoresistance Study on DolCas BCM-95 Shows Excellent Results

LANDING, New Jersey, September 19, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 19 Sep 2017

CVS Health Announces Support for Critical Rebuilding Efforts Following Historic Hurricanes

WOONSOCKET, R.I., Sept. 19, 2017 /PRNewswire/ -- Following the devastating damage caused by recent hurricanes, CVS Health (NYSE: CVS) today launched an in-store customer donation campaign to support the rebuilding efforts underway in the impacted areas. As part of this initiative, the company... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2017
Related companies:  CVS Health Corporation

Algatech Offers Organic, Non-GMO Natural Astaxanthin

KIBBUTZ KETURA, Israel, September 19, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 19 Sep 2017

BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2017 Healthcare Conference

RALEIGH, N.C., Sept. 19, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, Vice Chairman, President and Chief Executive Officer, will present at two upcoming healthcare conferences.

Read more ››
By: PR Newswire Association LLC. - 19 Sep 2017
Related companies:  BioDelivery Sciences International, Inc.

PDL BioPharma Updates Presentation Time for Cantor Fitzgerald Conference

INCLINE VILLAGE, Nev., Sept. 19, 2017 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, PDL's chief executive officer, will present at the 2017 Cantor Fitzgerald Global Healthcare Conference in New York City on Tuesday, September 26, 2017,... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2017

Pfenex To Present at the Cantor Fitzgerald Global Healthcare Conference on September 27th, 2017

SAN DIEGO, Sept. 19, 2017 /PRNewswire/ -- Pfenex Inc. (NYSE MKT: PFNX) announced today that it will be presenting at the Cantor Fitzgerald Global Healthcare Conference on September 27(th), 2017 at 4:00 pm ET. The conference will be held at the Intercontinental New York Barclay Hotel, New York.... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2017
Related companies:  Pfenex Inc.

Sepsis Power Hour Solution Accelerates Care, Reduces Costly Treatment Measures

SEATTLE, Sept. 19, 2017 /PRNewswire/ -- Sepsis is the primary cause of death from infection worldwide, with over 18 million cases per year, and represents the most costly condition treated within hospitals in the United States, hitting 20 billion dollars in 2011 alone.(1,2) Reducing delays in... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2017

RXi Pharmaceuticals to Present at Ladenburg Thalmann Healthcare Conference

MARLBOROUGH, Mass., Sept. 19, 2017 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical needs, announced today that Dr. Gerrit Dispersyn, RXi's Chief Development Officer, will present... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2017
Related companies:  RXi Pharmaceuticals Corporation

InMed Retains Consultant Ben Paterson for Biosynthesis Development

CSE: IN
OTCQB: IMLFF

Read more ››
By: PR Newswire Association LLC. - 19 Sep 2017
Related companies:  InMed Pharmaceuticals Inc.

Prometic Reports Positive Clinical Data from Ongoing PBI-4050 Study in Alström Syndrome Patients

LAVAL, QC, Sept. 19, 2017 /PRNewswire/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) (Prometic) today announced that longer-term data from its on-going phase 2 open label clinical trial in subjects suffering from Alström Syndrome in the United Kingdom confirm that the beneficial... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2017
Related companies:  ProMetic Life Sciences Inc.

Medical Cannabis Technology Company Successfully Completes First of Its Kind Study in California

Machine Learning-based Smart Inhaler for Medical Cannabis
Moves a Step Closer to Launching

Read more ››
By: PR Newswire Association LLC. - 19 Sep 2017

TiGenix Business and Financial Update for the First Half 2017

Read more ››
By: Nasdaq / GlobenewsWire - 19 Sep 2017
Related companies:  TiGenix NV

As Healthcare Pivots, Rx.Health Defines Digital Medicine

NEW YORK, Sept. 19, 2017 /PRNewswire/ -- Signaling a new era of patient care, Responsive Health is leading the most innovative names in healthcare as the company rebrands... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2017

Fewer than half of U.S. women take recommended vitamins prior to pregnancy, according to March of Dimes new Prenatal Health & Nutrition Survey

WHITE PLAINS, N.Y., Sept. 19, 2017 /PRNewswire-USNewswire/ -- Women of childbearing age need more education to ensure their own health and that of their babies both before and during pregnancy, according to findings from the new Prenatal Health & Nutrition survey of U.S. women announced... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2017
Related companies:  Mission Pharmacal Company

Anecova: First Babies Born in Poland with AneVivo Natural Fertilisation

LAUSANNE, Switzerland, September 19, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 19 Sep 2017

Health Care Is Unaffordable For Half the Country; Consumers & Physicians Agree On Why

HOUSTON, Sept. 19, 2017 /PRNewswire/ -- Consumers and physicians alike blame insurance companies, drug companies and medical device manufacturers for rising health care costs, according to results of a new nationwide survey produced by the Read more ››

By: PR Newswire Association LLC. - 19 Sep 2017

Trelegy Ellipta approved as the first once-daily single inhaler triple therapy for the treatment of appropriate patients with COPD in the US

LONDON, Sept. 18, 2017 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily, single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI), under the... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2017
Related companies:  GlaxoSmithKline plc

Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

WALTHAM, Mass., Sept. 18, 2017 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock (NYSE: ALR-B). The dividend is payable on October 16, 2017 to holders of record of... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2017
«  1  2  3  4  5  6  7  8  9  10 11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 40,000 companies